A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge

This publication has 53 references indexed in Scilit:

• Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV
  Journal of General Virology, 2003
• Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy
  The Journal of Infectious Diseases, 2000
• Enhanced Pulmonary Pathology in Cotton Rats upon Challenge After Immunization with Inactivated Parainfluenza Virus 3 Vaccines
  Viral Immunology, 2000
• Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model
  Vaccine, 1996
• Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants
  The Pediatric Infectious Disease Journal, 1996
• The complete nucleotide sequence of the JS strain of human parainfluenza virus type 3: comparison with the Wash/47885/57 prototype strain
  Virus Research, 1992
• Function and immunogenicity of human parainfluenza virus 3 glycoproteins expressed by recombinant adenoviruses
  Virus Research, 1992
• Attenuation of Bovine Parainfluenza Virus Type 3 in Nonhuman Primates and Its Ability to Confer Immunity to Human Parainfluenza Virus Type 3 Challenge
  The Journal of Infectious Diseases, 1988
• Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers
  Journal of Medical Virology, 1982
• Parainfluenza Type 3 Virus Infection in Hamsters: Virologic, Serologic, and Pathologic Studies
  The Journal of Infectious Diseases, 1964